Federal award
NOVARTIS PHARMACEUTICALS CORPORATION
HT001425PE011
Contract
Obligated and Ceiling
- Obligated (net)
- $402,591.14
- Ceiling (potential value, not spending)
- $402,591.14
- Current value
- $402,591.14
- Gross positive obligations
- $402,591.14
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NOVARTIS PHARMACEUTICALS CORPORATION · NG61ZA8TADW3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NOVARTIS SANIERUNGSSTIFTUNG · YE3YG1FDWMC5
- Awarding agency
- Department of War · sub-agency 97DH · office HT0014
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- HT001425PE011
- Award type code
- B
- Actions
- 1 · Sep 8, 2025 to Sep 8, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 8, 2025 | FY2025 | 0 | — | $402,591.14 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.